Outcomes were evaluated among children born between April 1980 and June 2019 by using data from 12 observational birth ...

While the tax exclusion for employer-sponsored health care was not included in the House-passed reconciliation bill, it ...

A combination of acalabrutinib and venetoclax showed better results with the addition of obinutuzumab, whereas mixed findings ...

Skepticism still persists around the use of measurable residual disease (MRD) for clinical and regulatory decision-making in ...

The Trump administration has ended a program seeking a vaccine for HIV, the first in a series of decisions that is leaving ...

Nonalcoholic fatty liver disease (NAFLD) was linked to elevated liver enzymes in type 2 diabetes mellitus (T2DM) in a recent ...

Bringing this interview with Marla Black Morgan, MD, to a close, she looks to the future of research in both myasthenia ...

A panelist discusses how bleeding risk assessment depends on platelet count levels (highest risk below 20,000), requiring ...

Vitiligo Awareness Month and World Vitiligo Day aim to educate the public about the autoimmune skin condition's complex ...

A panelist discusses how dry eye disease involves tear film imbalance, leading to inflammation and ocular surface damage, ...

Early results from the phase 1 SANRECO trial suggest that divesiran is safe and well tolerated, and may reduce the need for phlebotomy in patients with polycythemia vera by increasing hepcidin levels ...

Initiating fecal immunochemical test (FIT) screening before age 50 can significantly reduce colorectal cancer incidence and ...